C12N2750/10071 - CPC Classification Index

#1

20260069672

2026-03-12

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

#2

20250018022

2025-01-16

NOVEL RECOMBINANT PORCINE CIRCOVIRUS TYPE 2 PROTEIN AND USE THEREOF

#3

20240226264

2024-07-11

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

#4

20230338500

2023-10-26

A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG

#5

20230302113

2023-09-28

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

#6

20210128712

2021-05-06

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

#7

20210059951

2021-03-04

Vaccine treatment and control infectious against viral pathogens utilizing heparan sulfate (HS) as cellular receptor

#8

20180236057

2018-08-23

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#9

20180080042

2018-03-22

Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies

#10

20170216424

2017-08-03

Vaccine for PCV2 and mycoplasma

#11

20170087241

2017-03-30

Prevention and treatment of sub-clinical PCVD

#12

20170049875

2017-02-23

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#13

20160303218

2016-10-20

Vaccine against Lawsonia intracellularis and porcine circovirus 2

#14

20160220658

2016-08-04

PCV2B divergent vaccine composition and methods of use

#15

20160193320

2016-07-07

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#16

20160046676

2016-02-18

Fusion polypeptides and vaccines

#17

20150343052

2015-12-03

Prevention and treatment of sub-clinical PCVD

#18

20150297709

2015-10-22

Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof

#19

20150190498

2015-07-09

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#20

20150174233

2015-06-25

PCV2 immunogenic compositions and methods of producing such compositions

#21

20120164170

2012-06-28

Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof

#22

20110217327

2011-09-08

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#23

20110182935

2011-07-28

Prevention and treatment of sub-clinical PCVD

#24

20090317423

2009-12-24

PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

#25

20090010954

2009-01-08

Prevention and treatment of sub-clinical PCVD

#26

20080279889

2008-11-13

USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS

#27

20080279876

2008-11-13

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#28

20080279875

2008-11-13

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#29

20080267995

2008-10-30

USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS

#30

20080261887

2008-10-23

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#31

20080260779

2008-10-23

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#32

20080181910

2008-07-31

USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS

#33

20070065457

2007-03-22

Circovirus sequences associated with piglet weight loss disease (PWD)

#34

20060222659

2006-10-05

Circovirus sequences associated with piglet weight loss disease (PWD)

#35

20050238662

2005-10-27

Circovirus sequences associated with piglet weight loss disease (PWD)